IMMUNOME INC's ticker is and the CUSIP is 45257U908. A total of 2 filers reported holding IMMUNOME INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40,080 | -53.5% | 4,800 | -56.0% | 0.00% | – |
| Q2 2023 | $86,219 | +1627.8% | 10,900 | +990.0% | 0.00% | – |
| Q1 2023 | $4,990 | -9.3% | 1,000 | -60.0% | 0.00% | – |
| Q4 2022 | $5,500 | +37.5% | 2,500 | +150.0% | 0.00% | – |
| Q3 2022 | $4,000 | -66.7% | 1,000 | -73.0% | 0.00% | – |
| Q2 2022 | $12,000 | -42.9% | 3,700 | 0.0% | 0.00% | – |
| Q1 2022 | $21,000 | -89.4% | 3,700 | -75.8% | 0.00% | – |
| Q4 2021 | $198,000 | -44.7% | 15,300 | +4.1% | 0.00% | – |
| Q3 2021 | $358,000 | – | 14,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 14,700 | $358,000 | 0.00% |